Mary M.E. Crossey

Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

Marco Carbone, Alessandra Nardi, Steve Flack et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 163 citations · Full text

Medicine, Internal Medicine, Hepatology +9

Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function

Jasmohan S. Bajaj, I. Jane Cox, Naga S. Betrapally et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2014 · 139 citations

Medicine, Microbiology, Pharmacology +17

A double blind, placebo‐controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection

Janice Main, Jonathan Brown, C. H. L. Howells et al. · Journal of Viral Hepatitis · 1996 · 127 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis

Mark McPhail, Debbie L. Shawcross, Matthew R. Lewis et al. · Journal of Hepatology · 2016 · 93 citations · Full text

Life Sciences, Biochemistry, Metabolic Physiology +16

A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy

Jasmohan S. Bajaj, Patrick M. Gillevet, Neeral R. Patel et al. · Metabolic Brain Disease · 2012 · 92 citations

Medicine, Pharmacology, Physiology +15